Expression and purification of recombinant protein related to DAN and cerberus (PRDC)

Protein Expression and Purification

Volumn 82, Issue 2, 2012, Pages 389-395

  Kattamuri, Chandramohan ^a   Luedeke, David M ^a   Thompson, Thomas B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

BMP antagonist; Oxidative refolding; TGF family

Indexed keywords

BONE MORPHOGENETIC PROTEIN; GREM2 PROTEIN, MOUSE; LUCIFERASE; PROTEIN; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL INCLUSION; CELL LINE; CHEMICAL PHENOMENA; CHEMISTRY; DRUG ANTAGONISM; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN BINDING; PROTEIN REFOLDING; PROTEIN SECONDARY STRUCTURE; REPORTER GENE; REVERSED PHASE LIQUID CHROMATOGRAPHY; SIGNAL TRANSDUCTION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL LINE; CHROMATOGRAPHY, REVERSE-PHASE; GENE EXPRESSION; GENES, REPORTER; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INCLUSION BODIES; LUCIFERASES; MICE; PROTEIN BINDING; PROTEIN REFOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEINS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84857969097     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2012.02.010     Document Type: Article

References (45)

1. L. Attisano, and J.L. Wrana Signal transduction by the TGF-beta superfamily Science 296 2002 1646 1647
2. H. Chang, C.W. Brown, and M.M. Matzuk Genetic analysis of the mammalian transforming growth factor-beta superfamily Endocr. Rev. 23 2002 787 823
3. B.L. Hogan Bone morphogenetic proteins in development Curr. Opin. Genet. Dev. 6 1996 432 438
4. D.M. Kingsley The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms Genes Dev. 8 1994 133 146
5. J. Massague How cells read TGF-beta signals Nat. Rev. Mol. Cell. Biol. 1 2000 169 178
6. R. Derynck TGF-beta-receptor-mediated signaling Trends Biochem. Sci. 19 1994 548 553
7. Y. Shi, and J. Massague Mechanisms of TGF-beta signaling from cell membrane to the nucleus Cell 113 2003 685 700
8. J. Groppe, J. Greenwald, E. Wiater, J. Rodriguez-Leon, A.N. Economides, W. Kwiatkowski, M. Affolter, W.W. Vale, J.C. Belmonte, and S. Choe Structural basis of BMP signalling inhibition by the cystine knot protein Noggin Nature 420 2002 636 642
9. A.E. Harrington, S.A. Morris-Triggs, B.T. Ruotolo, C.V. Robinson, S. Ohnuma, and M. Hyvonen Structural basis for the inhibition of activin signalling by follistatin EMBO J. 25 2006 1035 1045
10. T.B. Thompson, T.F. Lerch, R.W. Cook, T.K. Woodruff, and T.S. Jardetzky The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding Dev. Cell 9 2005 535 543
11. R. Stamler, H.T. Keutmann, Y. Sidis, C. Kattamuri, A. Schneyer, and T.B. Thompson The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity J. Biol. Chem. 283 2008 32831 32838
12. T.F. Lerch, S. Shimasaki, T.K. Woodruff, and T.S. Jardetzky Structural and biophysical coupling of heparin and activin binding to follistatin isoform functions J. Biol. Chem. 282 2007 15930 15939
13. J.N. Cash, C.A. Rejon, A.C. McPherron, D.J. Bernard, and T.B. Thompson The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding EMBO J. 28 2009 2662 2676
14. O. Hashimoto, N. Kawasaki, K. Tsuchida, S. Shimasaki, T. Hayakawa, and H. Sugino Difference between follistatin isoforms in the inhibition of activin signalling: activin neutralizing activity of follistatin isoforms is dependent on their affinity for activin Cell Signal. 12 2000 565 571
15. S. Keller, J. Nickel, J.L. Zhang, W. Sebald, and T.D. Mueller Molecular recognition of BMP-2 and BMP receptor IA Nat. Struct. Mol. Biol. 11 2004 481 488
16. N. Kusu, J. Laurikkala, M. Imanishi, H. Usui, M. Konishi, A. Miyake, I. Thesleff, and N. Itoh Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity J. Biol. Chem. 278 2003 24113 24117
17. D.R. Hsu, A.N. Economides, X. Wang, P.M. Eimon, and R.M. Harland The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities Mol. Cell 1 1998 673 683
18. J.J. Pearce, G. Penny, and J. Rossant A mouse cerberus/Dan-related gene family Dev, Biol, 209 1999 98 110
19. L.Z. Topol, M. Marx, D. Laugier, N.N. Bogdanova, N.V. Boubnov, P.A. Clausen, G. Calothy, and D.G. Blair Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture Mol. Cell Biol. 17 1997 4801 4810
20. L.B. Zimmerman, J.M. De Jesus-Escobar, and R.M. Harland The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4 Cell 86 1996 599 606
21. J.J. Ross, O. Shimmi, P. Vilmos, A. Petryk, H. Kim, K. Gaudenz, S. Hermanson, S.C. Ekker, M.B. O'Connor, and J.L. Marsh Twisted gastrulation is a conserved extracellular BMP antagonist Nature 410 2001 479 483
22. W. Balemans, and W. Van Hul Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators Dev. Biol. 250 2002 231 250
23. S. Sudo, O. Avsian-Kretchmer, L.S. Wang, and A.J. Hsueh Protein related to DAN and cerberus is a bone morphogenetic protein antagonist that participates in ovarian paracrine regulation J. Biol. Chem. 279 2004 23134 23141
24. C. Minabe-Saegusa, H. Saegusa, M. Tsukahara, and S. Noguchi Sequence and expression of a novel mouse gene PRDC (protein related to DAN and cerberus) identified by a gene trap approach Dev. Growth Differ. 40 1998 343 353
25. H. Ideno, R. Takanabe, A. Shimada, K. Imaizumi, R. Araki, M. Abe, and A. Nifuji Protein related to DAN and cerberus (PRDC) inhibits osteoblastic differentiation and its suppression promotes osteogenesis in vitro Exp. Cell Res. 315 2009 474 484
26. O. Avsian-Kretchmer, and A.J. Hsueh Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists Mol. Endocrinol. 18 2004 1 12
27. V. Veverka, A.J. Henry, P.M. Slocombe, A. Ventom, B. Mulloy, F.W. Muskett, M. Muzylak, K. Greenslade, A. Moore, L. Zhang, J. Gong, X. Qian, C. Paszty, R.J. Taylor, M.K. Robinson, and M.D. Carr Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation J. Biol. Chem. 284 2009 10890 10900
28. S.E. Weidauer, P. Schmieder, M. Beerbaum, W. Schmitz, H. Oschkinat, and T.D. Mueller NMR structure of the Wnt modulator protein Sclerostin Biochem. Biophys. Res. Commun. 380 2009 160 165
29. J.J. Cacciatore, L.A. Chasin, and E.F. Leonard Gene amplification and vector engineering to achieve rapid and high-level therapeutic protein production using the Dhfr-based CHO cell selection system Biotechnol. Adv. 28 2010 673 681
30. E.D.B. Clark Refolding of recombinant proteins Curr. Opin. Biotechnol. 9 1998 157 163
31. L.F. Vallejo, and U. Rinas Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins Microb. Cell Fact. 3 2004 11
32. J. Buchner, and R. Rudolph Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli Biotechnology (NY) 9 1991 157 162
33. R. Rudolph Renaturation of recombinant, disulfide-bonded proteins from inclusion bodies H. Tschesche, Modern methods in protein and nucleic acid research 1990 149 171
34. K. Shiraki, M. Kudou, S. Fujiwara, T. Imanaka, and M. Takagi Biophysical effect of amino acids on the prevention of protein aggregation J. Biochem. 132 2002 591 595
35. W.W. Chan A method for the complete S sulfonation of cysteine residues in proteins Biochemistry 7 1968 4247 4254
36. B. Fischer, I. Sumner, and P. Goodenough Isolation, renaturation, and formation of disulfide bonds of eukaryotic proteins expressed in Escherichia-coli as inclusion-bodies Biotechnol. Bioeng. 41 1993 3 13
37. A.P. Middelberg Preparative protein refolding Trends Biotechnol. 20 2002 437 443
38. A.N. Economides, N. Stahl, DCR5, A BMP-Binding protein, and applications thereof, US Patent No. 6660,499 B1, 2003.
39. J. Im, H. Kim, S. Kim, and E.H. Jho Wnt/beta-catenin signaling regulates expression of PRDC, an antagonist of the BMP-4 signaling pathway Biochem. Biophys. Res. Commun. 354 2007 296 301
40. B. Herrera, and G.J. Inman A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum BMC Cell Biol. 10 2009 20
41. J.N. Cash, E.B. Angerman, C. Kattamuri, K. Nolan, H. Zhao, Y. Sidis, H.T. Keutmann, and T.B. Thompson Structure of Myostatin{middle dot}Follistatin-like 3: N-terminal domains of Follistatin-type molecules exhibit alternate modes of binding J. Biol. Chem. 287 2012 1043 1053
42. M.A. Andrade, P. Chacon, J.J. Merelo, and F. Moran Evaluation of secondary structure of proteins from UV circular dichroism spectra using an unsupervised learning neural network Protein Eng. 6 1993 383 390
43. L. Whitmore, and B.A. Wallace Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases Biopolymers 89 2008 392 400
44. L. Whitmore, and B.A. Wallace DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data Nucleic Acids Res. 32 2004 W668 673
45. W.C. Johnson Analyzing protein circular dichroism spectra for accurate secondary structures Proteins 35 1999 307 312